Autologous cellular therapy for cerebral palsy: a randomized, crossover trial

We examined an autologous mononuclear-cell-therapy-based approach to treat cerebral palsy using autologous umbilical cord blood or bone-marrow-derived mononuclear cells. The primary objective was to determine if autologous cells are safe to administer in children with cerebral palsy. The secondary o...

Descripción completa

Detalles Bibliográficos
Autores principales: Cox, Charles S., Juranek, Jenifer, Kosmach, Steven, Pedroza, Claudia, Thakur, Nivedita, Dempsey, Allison, Rennie, Kimberly, Scott, Michael C., Jackson, Margaret, Kumar, Akshita, Aertker, Benjamin, Caplan, Henry, Triolo, Fabio, Savitz, Sean I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188321/
https://www.ncbi.nlm.nih.gov/pubmed/35702731
http://dx.doi.org/10.1093/braincomms/fcac131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188321/
https://www.ncbi.nlm.nih.gov/pubmed/35702731
http://dx.doi.org/10.1093/braincomms/fcac131

Ejemplares similares